Compounds > ciprofloxacin

ciprofloxacin and iodine

ciprofloxacin has been researched along with iodine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	3 (42.86)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Hawary, WF; Moussa, MA; Refat, MS	1
Metz, R; Muth, P; Naber, K; Seelmann, R; Sorgel, F	1
Høiby, N; Johansen, HK	1
Hawkey, PM	1
Bangsborg, JM; Hansen, H; Høiby, N; Jarløv, JO; Kemp, M; Kjerulf, A; Pers, C; Tvede, M	1
Akhtar, M; Anwar, MI; Haider, H; Javed, I; Khan, MZ; Muhammad, F; Rahman, ZU; Zafar, M	1
Buchard, A; Dalbøge, CS; Dalhoff, K; Duno, M; Høiby, N; Johansen, HK; Nielsen, XC; Pressler, T; Schultz, AN; Wang, H	1

Other Studies

7 other study(ies) available for ciprofloxacin and iodine

Article	Year
IR, 1H NMR, mass, XRD and TGA/DTA investigations on the ciprofloxacin/iodine charge-transfer complex. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2011, Volume: 78, Issue:5 Topics: Absorption; Chloroform; Ciprofloxacin; Electrons; Iodine; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Weight; Photometry; Protons; Spectrophotometry, Infrared; Temperature; Thermogravimetry; Titrimetry; X-Ray Diffraction	2011
Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D Topics: Adult; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Fleroxacin; Half-Life; Humans; Kidney; Male; Saliva; Sweat; Tears	1988
Ciprofloxacin in sweat and antibiotic resistance. The Copenhagen Study Group on Antibiotics in Sweat. Lancet (London, England), 1995, Nov-04, Volume: 346, Issue:8984 Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Sweat	1995
Quinolones in sweat and quinolone resistance. Lancet (London, England), 1997, Jan-18, Volume: 349, Issue:9046 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Mutation; Staphylococcus aureus; Staphylococcus epidermidis; Sweat	1997
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet (London, England), 1997, Jan-18, Volume: 349, Issue:9046 Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Staphylococcus epidermidis; Sweat	1997
Dermatotoxic effects of orally administered ciprofloxacin in sweating and nonsweating animal models. Cutaneous and ocular toxicology, 2010, Volume: 29, Issue:4 Topics: Administration, Oral; Animals; Anti-Infective Agents; Biopsy; Chromatography, High Pressure Liquid; Ciprofloxacin; Epidermis; Goats; Models, Animal; Rabbits; Sweat; Sweating	2010
Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients. Pediatric pulmonology, 2017, Volume: 52, Issue:3 Topics: Adult; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Cystic Fibrosis; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sweat; Young Adult	2017